Musk Pills with a diameter of only 2.85 mm,
But it is a classic Chinese medicine for the prevention and treatment of coronary heart disease,
It is also owned by Shanghai Hehuang Pharmaceutical Co., Ltd
"Star Product"
Cholexin tablets, positive qi tablets
In recent years, it has also become a "new favorite" in the market.
For more than 40 years, enterprises have been born one after another
74 modern Chinese medicine products,
And technological innovation
It is the only magic weapon to enhance the core competitiveness of enterprises.
On July 21, at the Shanghai Industrial Technology Innovation Conference, Shanghai Hehuang Pharmaceutical Co., Ltd. was awarded the honorary title of 2021 National Technological Innovation Demonstration Enterprise, becoming one of the two enterprises in the city that received this honor. This chinese medicine track leader rooted in the Oriental Meigu has "walked on two legs" in promoting the modernization and internationalization of Chinese medicine, and has stepped out of the new paradigm of Chinese medicine empowering healthy China.
In the workshop of Hehuang Pharmaceutical, 12.6 million musk baoxin pills will be born every day, which is equivalent to 420 pills per second, and the Japanese Kampo medicine "Heart Saving Dan" was sold in China in the last century, which directly contributed to the birth of Musk Baoxin Pills. Experts such as the former Shanghai Traditional Chinese Medicine Pharmaceutical Factory [Shanghai Hehuang Pharmaceutical] and Professor Dai Ruihong have spent nearly ten years of painstaking efforts to take the aromatic Wentong representative formula Su He Xiang Pill in the "Taiping Huimin and Pharmacy Bureau Fang" as the foundation, to remove the wu cun jing, and after the crown heart Su He Pill, Su Bing Drop Pill, Ginseng Su He Xiang Pill, etc., and finally make the ancient Fang be perfectly reborn as the musk Baoxin Pill.
In 2001, Shanghai established the first Chinese medicine joint venture - Shanghai Hehuang Pharmaceutical, and after the establishment of the joint venture, Hehuang Pharmaceutical co., Ltd. adhered to the purpose of "innovating traditional Chinese medicine and serving healthy China" and continuously promoted the modernization and internationalization of Chinese medicine. "The public's greatest concern about Chinese medicine is whether it has curative effects." Liu Xianyang, director of the production center of Shanghai Hehuang Pharmaceutical Co., Ltd., introduced that the company focused on the clinical value of the product, and confirmed the clinical efficacy and safety of musk baoxin pills with modern research and scientific data by carrying out clinical research and conducting evidence-based medical research on nearly 3,000 patients.
Of course, Hehuang Pharmaceutical has not stopped in the development of a drug. In 2016 and 2019, Chonin Tablets obtained the Canadian Natural Medicine Marketing License and the production site certification outside Canada, becoming the first "Shangyao Brand" compound Chinese medicine to go abroad. This company, which has been developed over 8 years, originates from the prescription of Zhu Peiting, a professor at Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine, and is composed of 7 flavor medicines, which have the effect of soothing liver choleretic and clearing heat. "This marks an important step in the internationalization of chinese medicine in mainland China." Liu Xianyang said.
In the process of prevention and treatment of the new crown epidemic in recent years, traditional Chinese medicine is also playing an advantage. Hehuang Pharmaceutical's Zhengqi tablets are one of them. Zhengqi tablets originated from the Song Dynasty's "Taiping Huimin and Pharmacy Bureau Fang" Huoxiang Zhengqi Fang, which has the effect of diverging wind chill, reducing dampness and neutralizing. In April this year, the Shanghai Municipal Health Commission and the Shanghai Municipal Administration of Traditional Chinese Medicine carried out the project "Research on the Clinical Observation and Mechanism of Positive Gas Tablets for Asymptomatic Covid-19 Infected Persons" and found that positive gas tablets can improve the nucleic acid negative conversion rate, and within 2 days, a better nucleic acid negative effect can occur.
Currently, for osteoporosis bone pain,
Acute phase of ischemic stroke,
Alzheimer's disease, etc.,
Hehuang Pharmaceutical is also conducting research and development of 12 new products.
"At present, we have a R&D team of 165 people, and the second phase of the R&D building will also be put into use this year. Shouzheng innovation, we will continue to move forward on the road of inheritance and development of traditional Chinese medicine. Liu Xianyang said confidently.
Reporter: Zhang Lili Shi Haonan
Editor: He Yuxin